Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PixelFox | PIXEL | Dec 30, 2024 | 0.41 | 0.00 |
Platzer Fastigheter Holding AB (publ) | PLAZB | Dec 30, 2024 | 85.70 | +1.06 |
Plejd | PLEJD | Dec 30, 2024 | 370.00 | +1.65 |
PMD Device Solutions | PMDS | Dec 30, 2024 | 0.66 | 0.00 |
PolarCool | POLAR | Dec 30, 2024 | 8.10 | -1.22 |
Polygiene | POLYG | Dec 30, 2024 | 12.45 | -5.68 |
Polyplank | POLY | Dec 30, 2024 | 0.02 | -9.80 |
PowerCell Sweden | PCELL | Dec 30, 2024 | 35.46 | -0.39 |
Prebona | PREBON | Dec 30, 2024 | 3.40 | +3.66 |
Precio Fishbone B | PRCOB | Dec 30, 2024 | 21.80 | -0.91 |
Precise Biometrics | PREC | Dec 30, 2024 | 4.93 | -1.30 |
Precomp Solutions B | PCOMB | Dec 30, 2024 | 0.84 | -15.50 |
Premium Snacks Nordic | SNX | Dec 30, 2024 | 17.40 | 0.00 |
Preservia Hyresfastigheter B | PHYRB | Dec 30, 2024 | 0.10 | -12.17 |
Preservia Hyresfastigheter PREF | PHYRPREF | Dec 30, 2024 | 35.00 | 0.00 |
Preservium Property | PRESRV | Dec 30, 2024 | 46.80 | +7.83 |
Prevas B | PREVB | Dec 30, 2024 | 118.60 | +1.72 |
Pricer B | PRICB | Dec 30, 2024 | 11.72 | -2.01 |
Prisma Properties AB | PRISMA | Dec 30, 2024 | 23.80 | -1.51 |
Proact IT Group | PACT | Dec 30, 2024 | 117.80 | -1.01 |
Probi | PROB | Dec 30, 2024 | 349.00 | -0.29 |
ProfilGruppen B | PROFB | Dec 30, 2024 | 99.20 | +0.20 |
Profoto Holding | PRFO | Dec 30, 2024 | 44.00 | +6.80 |
Projektengagemang Sweden B | PENGB | Dec 30, 2024 | 8.54 | 0.00 |
Prolight Diagnostics | PRLD | Dec 30, 2024 | 0.13 | +0.75 |
Promimic AB | PRO | Dec 30, 2024 | 22.50 | -1.32 |
ProstaLund | PLUN | Dec 30, 2024 | 7.54 | -10.24 |
Prostatype Genomics | PROGEN | Dec 30, 2024 | 11.10 | +9.90 |
Provide IT | PROVIT | Dec 30, 2024 | 1.59 | +4.26 |
Purefun | PURE | Dec 30, 2024 | 12.50 | -3.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.